344 consecutive patients
who underwent CAS from 2002 to 2012. Statins were
associated with a periprocedural risk reduction in the
incidence of ischemic stroke, MI, or death (OR, 0.31;
95% CI, 0.3-0.71; P Â¼ .006).95 The largest case series reported to date includes 1083 patients who underwent
